Il Dong Pharmaceutical Co Ltd (249420) — Capital Reinvestment Ratio
Latest as of September 2025:
0.53x
Il Dong Pharmaceutical Co Ltd (249420) has a Capital Reinvestment Ratio of 0.53x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩11.28 Billion) in capital expenditures (₩5.97 Billion). See Il Dong Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.53x
Capex / Operating Cash Flow
Operating Cash Flow
₩11.28 Billion
KRW
Capital Expenditures
₩5.97 Billion
KRW
Data as of
Sep 2025
Most recent filing
Il Dong Pharmaceutical Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Il Dong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Il Dong Pharmaceutical Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Il Dong Pharmaceutical Co Ltd from 2016 to 2024. For live market cap and broader valuation context, see 249420 market cap.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.50x | ₩28.29 Billion | ₩14.05 Billion | ▼ -33.0% |
| 2020 | 0.74x | ₩19.37 Billion | ₩14.35 Billion | ▲ +154.2% |
| 2019 | 0.29x | ₩41.37 Billion | ₩12.06 Billion | ▲ +28.8% |
| 2018 | 0.23x | ₩66.65 Billion | ₩15.09 Billion | ▼ -0.2% |
| 2017 | 0.23x | ₩73.72 Billion | ₩16.73 Billion | ▼ -26.6% |
| 2016 | 0.31x | ₩45.98 Billion | ₩14.22 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow